Jeffery H. Moran
Affiliations: | Pharmacology | University of Arkansas for Medical Sciences, United States |
Area:
Pharmacology, Analytical ChemistryGoogle:
"Jeffery Moran"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hutchison RD, Ford BM, Franks LN, et al. (2018) Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ-THC. Frontiers in Pharmacology. 9: 1084 |
| Patton AL, Jones JO, Nord A, et al. (2018) Multi-laboratory validation of a Δ9-tetrahydrocannabinol LC-MS/MS test kit designed for quantifying THC and marijuana metabolites in blood. Forensic Science and Criminology. 3 |
| Patton AL, Seely KA, Yarbrough AL, et al. (2018) Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants. Biochemical and Biophysical Research Communications |
| Su MK, Seely KA, Moran JH, et al. (2015) Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018. Clinical Pharmacology and Therapeutics. 97: 562-4 |
| Patton AL, Seely KA, Pulla S, et al. (2014) Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS. Analytical Chemistry. 86: 1760-6 |
| Fantegrossi WE, Moran JH, Radominska-Pandya A, et al. (2014) Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? Life Sciences. 97: 45-54 |
| Chimalakonda KC, James LP, Radominska-Pandya A, et al. (2013) Sulfaphenazole and α-naphthoflavone attenuate the metabolism of the synthetic cannabinoids JWH-018 and AM2201 found in K2/spice. Drug Metabolism Letters. 7: 34-8 |
| Seely KA, Patton AL, Moran CL, et al. (2013) Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Science International. 233: 416-22 |
| Patton AL, Seely KA, Chimalakonda KC, et al. (2013) Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology. Analytical Chemistry. 85: 9390-9 |
| Patton AL, Chimalakonda KC, Moran CL, et al. (2013) K2 toxicity: fatal case of psychiatric complications following AM2201 exposure. Journal of Forensic Sciences. 58: 1676-80 |